Comprehensive Literature Review and Evidence evaluation of Experimental Treatment in COVID 19 Contagion.

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Accounts of Chemical Research Pub Date : 2020-10-21 eCollection Date: 2020-01-01 DOI:10.1177/1179548420964140
Umesha Boregowda, Darshan Gandhi, Nitin Jain, Kanika Khanna, Nishant Gupta
{"title":"Comprehensive Literature Review and Evidence evaluation of Experimental Treatment in COVID 19 Contagion.","authors":"Umesha Boregowda,&nbsp;Darshan Gandhi,&nbsp;Nitin Jain,&nbsp;Kanika Khanna,&nbsp;Nishant Gupta","doi":"10.1177/1179548420964140","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Coronavirus 2019 pandemic (COVID 19) is caused by the Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) virus. The pandemic is affecting the livelihood of millions of people all over the world. At the time of preparing this report, the pandemic has affected 1 827 284 patients, with 113 031 deaths in 185 countries as per Johns Hopkins University. With no proven treatment for the disease, prevention of the disease in the community and healthcare setting is need of the hour.</p><p><strong>Objective: </strong>To perform a comprehensive literature search for preventive measures and experimental treatment options. In this review, we have focused our discussion on the risk of disease transmission, supportive treatment, and possible treatment options based on available evidence.</p><p><strong>Evidence review: </strong>We performed a literature search on google scholar, PubMed, and society guidelines for literature related to COVID 19 and previous coronavirus pandemics. We included data review articles, observational studies, and controlled trials to synthesize the treatment options for COVID 19.</p><p><strong>Findings: </strong>In this article, we have extensively reviewed and discussed recommendations from various world organizations for the public and healthcare workers. We have also discussed currently available experimental treatments since there is no proven treatment for COVID 19. The best method of dealing with the current outbreak is to reduce the community spread and thus \"flatten the curve.\" Although Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, and Azithromycin have been tried, passive immunity through convalescent serum and vaccine is still at an experimental stage. Patients with severe COVID 19 infections could be considered for this experimental treatment through various national randomized control trials, which may eventually lead to an evidence-based treatment strategy.</p><p><strong>Conclusions and relevance: </strong>Awareness of currently available experimental treatment among healthcare providers and exploration of possible treatment options through evidence is need of the hour. We have discussed the most recently available literature and evidence behind experimental treatment in this article.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179548420964140","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1179548420964140","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 5

Abstract

Importance: Coronavirus 2019 pandemic (COVID 19) is caused by the Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) virus. The pandemic is affecting the livelihood of millions of people all over the world. At the time of preparing this report, the pandemic has affected 1 827 284 patients, with 113 031 deaths in 185 countries as per Johns Hopkins University. With no proven treatment for the disease, prevention of the disease in the community and healthcare setting is need of the hour.

Objective: To perform a comprehensive literature search for preventive measures and experimental treatment options. In this review, we have focused our discussion on the risk of disease transmission, supportive treatment, and possible treatment options based on available evidence.

Evidence review: We performed a literature search on google scholar, PubMed, and society guidelines for literature related to COVID 19 and previous coronavirus pandemics. We included data review articles, observational studies, and controlled trials to synthesize the treatment options for COVID 19.

Findings: In this article, we have extensively reviewed and discussed recommendations from various world organizations for the public and healthcare workers. We have also discussed currently available experimental treatments since there is no proven treatment for COVID 19. The best method of dealing with the current outbreak is to reduce the community spread and thus "flatten the curve." Although Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, and Azithromycin have been tried, passive immunity through convalescent serum and vaccine is still at an experimental stage. Patients with severe COVID 19 infections could be considered for this experimental treatment through various national randomized control trials, which may eventually lead to an evidence-based treatment strategy.

Conclusions and relevance: Awareness of currently available experimental treatment among healthcare providers and exploration of possible treatment options through evidence is need of the hour. We have discussed the most recently available literature and evidence behind experimental treatment in this article.

Abstract Image

Abstract Image

Abstract Image

COVID - 19传染病实验治疗的综合文献综述及证据评价。
重要性:2019冠状病毒大流行(COVID - 19)是由严重急性呼吸综合征冠状病毒2 (SARS - CoV-2)病毒引起的。这一流行病正在影响全世界千百万人的生计。在编写本报告时,根据约翰霍普金斯大学的数据,该大流行已影响185个国家的1827284名患者,113 031人死亡。由于这种疾病没有得到证实的治疗方法,在社区和卫生保健机构预防这种疾病是当务之急。目的:对预防措施和实验性治疗方案进行综合文献检索。在这篇综述中,我们集中讨论了疾病传播的风险、支持性治疗以及基于现有证据的可能治疗方案。证据审查:我们在google scholar、PubMed和社会指南中检索了与COVID - 19和以前的冠状病毒大流行相关的文献。我们纳入了数据综述文章、观察性研究和对照试验,以综合COVID - 19的治疗方案。研究结果:在本文中,我们广泛地回顾和讨论了各种世界组织为公众和医疗工作者提出的建议。我们还讨论了目前可用的实验性治疗方法,因为COVID - 19没有得到证实的治疗方法。应对当前疫情的最佳方法是减少社区传播,从而“拉平曲线”。虽然羟氯喹、雷姆德西韦、洛匹那韦/利托那韦、阿奇霉素等已被尝试,但通过恢复期血清和疫苗进行被动免疫仍处于实验阶段。可以通过各种国家随机对照试验,考虑重症患者接受这种实验性治疗,最终可能形成循证治疗策略。结论和相关性:卫生保健提供者认识到目前可用的实验性治疗,并通过证据探索可能的治疗方案是当务之急。我们在这篇文章中讨论了最近可用的文献和实验治疗背后的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信